- The Issue
- The Solutions
- News & Media
- Case Studies
- Policy Center
An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
For journalists and other media professionals
Recently, PIPC Chairman Tony Coelho participated in a radio interview on KDKA News Radio 1020 AM in Pittsburgh, PA, to talk about healthcare reform and specifically comparative effectiveness research (CER).
“I really agree that we need to reform healthcare,” Coelho said. He then went on to discuss CER and the need to keep this research patient-centered.
As the nation continues to focus on the health care debate, PIPC is maintaining its commitment to ensuring patient care – not cost – is the driving force behind new efforts to implement comparative effectiveness research (CER).
As Newsweek points out today, there’s a lot of information out there on health care reform. When it comes to comparative effectiveness research (CER), they rightfully state that “supporters of this type of research say it can provide valuable information to doctors, improving care and also lowering cost.”
In a recent op-ed House Speaker Nancy Pelosi and Majority Leader Steny Hoyer outlined some important components of health care reform, including their support for “research on health outcomes to better inform the decisions of patients and doctors.”